"Immunological monitoring of patients with melanoma after peptide vaccination using soluble peptide/HLA-A2 dimer complexes." by Hong-Ming Hu

Selected Works of Walter J. Urba, MD, PhD

Article

Immunological monitoring of patients with melanoma after peptide vaccination using soluble peptide/HLA-A2 dimer complexes.

Journal of Immunotherapy (2004)

Hong-Ming Hu, Providence Portland Medical Center
Annemieke Dols, Providence Portland Medical Center
Sybren L. Meijer, Providence Portland Medical Center
Kevin Floyd, Providence Portland Medical Center
Edwin Walker, Providence Portland Medical Center
Walter J. Urba, Providence Portland Medical Center
Bernard A. Fox, Providence Portland Medical Center

Link

Disciplines

Biology and
Immunology and Infectious Disease

Publication Date

January 1, 2004

DOI

10.1097/00002371-200401000-00005

Citation Information

Hong-Ming Hu, Annemieke Dols, Sybren L. Meijer, Kevin Floyd, et al.. "Immunological monitoring of patients with melanoma after peptide vaccination using soluble peptide/HLA-A2 dimer complexes." Journal of Immunotherapy Vol. 27 Iss. 1 (2004) p. 48 - 59
Available at: http://works.bepress.com/walter-urba/209/